Equiscale Logo
Equiscale
NSE / BSETechnology
β‚Ή544.60-3.70-0.67%
P/E62.0Mkt Capβ‚Ή7.45 K CrEV/EBITDA52.5

Thyrocare Technologies Limited

P/E62.0Mkt Capβ‚Ή7.45 K CrEV/EBITDA52.5
Company Profile

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 15 Sept 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Strengths1

  • Maintains healthy dividend payout of 134.0%

Concerns0

    Rule-based from financial data. Not advice.

    Price Historyβ–² 37.33% over 1Y
    Technical Chart

    Monthly Returns

    Unlock Monthly Returns

    Available on Pro and Institutional plans.

    Sign up free

    Year-to-Date ROI

    Unlock Year-to-Date ROI

    Available on Pro and Institutional plans.

    Sign up free

    Historical Volatility

    Unlock Historical Volatility

    Available on Pro and Institutional plans.

    Sign up free

    Historical Performance

    Revenue, profitability, and cash flow trends (β‚Ή Crores)

    Revenue (10Y)

    Operating Income (10Y)

    Net Profit (10Y)

    Operating Margin % (10Y)

    Dividend Payout % (10Y)

    Free Cash Flow (10Y)

    Growth Summary

    Latest fiscal year: Mar 2025

    Revenueβ‚Ή633.00 Crβ–² 20.8%
    EBITDA Growthβ€”
    Net Profitβ‚Ή96.00 Crβ–² 35.2%
    Cash from Ops (CFO)β€”
    Free Cash Flow (FCF)β€”β–Ό 233.3%
    Revenue CAGR 5Y5.5%
    EBITDA CAGR 5Y1.3%
    Net Profit CAGR 5Y-2.1%
    NP Growth 1Y35.2%

    Historical Growth

    Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

    YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
    Mar 2025β‚Ή633.00 Crβ€”β‚Ή96.00 Crβ€”β€”17.9%20.8%35.2%
    Mar 2024β‚Ή524.00 Crβ€”β‚Ή71.00 Crβ€”β€”13.8%7.8%24.6%
    Mar 2023β‚Ή486.00 Crβ€”β‚Ή57.00 Crβ€”β€”10.9%-13.5%-62.5%
    Mar 2022β‚Ή562.00 Crβ€”β‚Ή152.00 Crβ€”β€”29.2%18.6%26.7%
    Mar 2021β‚Ή474.00 Crβ€”β‚Ή120.00 Crβ€”β€”26.9%18.2%51.9%
    Mar 2020β‚Ή401.00 Crβ€”β‚Ή79.00 Crβ€”β€”20.9%8.4%-16.8%
    Mar 2019β‚Ή370.00 Crβ€”β‚Ή95.00 Crβ€”β€”20.8%11.4%-1.0%
    Mar 2018β‚Ή332.00 Crβ€”β‚Ή96.00 Crβ€”β€”21.1%11.4%104.3%
    Mar 2017β‚Ή298.00 Crβ€”β‚Ή47.00 Crβ€”β€”11.2%26.8%-20.3%
    Mar 2016β‚Ή235.00 Crβ€”β‚Ή59.00 Crβ€”β€”15.7%30.6%20.4%

    Financial Statements

    Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

    Free plan Β· showing 1 year of data.Upgrade

    Consolidated Figures in USD Millions.

    Unnamed: 0TTM
    Revenue / Net Sales708
    Total Expenses486
    EBIT / Operating Profit221
    OPM %31%
    Other Income14
    Finance Costs2
    Depreciation & Amortisation46
    Profit Before Tax188
    Tax %-
    Net Profit / PAT120
    EPS (β‚Ή)7.56
    Dividend Payout %-

    Peer Comparison

    Technology sector peers, ranked by market cap

    CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
    Thyrocare Technologies Limitedthis co.β‚Ή7.45 K Crβ‚Ή633.00 Cr62.0014.4352.5220.8%
    Bharti Airtel Ltd.β‚Ή12.19 L Crβ‚Ή1.09 L Cr50.408.3127.1915.8%
    Tata Consultancy Services Ltd.β‚Ή11.84 L Crβ‚Ή2.15 L Cr24.2013.9118.916.2%
    Infosys Ltdβ‚Ή6.48 L Crβ‚Ή1.37 L Cr24.207.1716.315.9%
    HCL Technologies Ltdβ‚Ή4.52 L Crβ‚Ή51.10 K Cr36.8014.48β€”6.2%
    Bharat Electronics Ltd.β‚Ή3.02 L Crβ‚Ή23.66 K Cr53.3014.2351.3217.3%
    Wipro Ltd.β‚Ή2.77 L Crβ‚Ή67.29 K Cr23.004.2918.850.8%
    Industry Averageβ€”β‚Ή10.05 K Cr69.998.5866.7522.0%

    Learn while you research

    Hand-picked academy chapters to deepen your understanding of Thyrocare Technologies Limited and the metrics that matter.

    01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read03 Valuation Multiples ExplainedThis stock trades at a P/E of 62.0, learn when high multiples are justified.6 min read04 Growth Investing21% revenue growth is in the top tier, learn how to value growth.7 min read05 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read

    Key concepts to brush up on

    P/E RatioP/B RatioROEROCEFree Cash FlowDebt / EquityLTCG Tax
    Browse the full Equiscale Academy